Location History:
- Osaka, JA (1977)
- Toyonaka, JA (1978)
- Toyonaka, JP (1979 - 1992)
- Hyogo, JP (1993)
- Osaka, JP (1980 - 2008)
- Itami, JP (1989 - 2014)
Company Filing History:
20 out of 174 
7 out of 6,896 
4 out of 140 
Years Active: 1977-2014
Title: The Innovations of Makoto Sunagawa: A Dive into His Patents and Career
Introduction: Makoto Sunagawa, a prominent inventor based in Itami, Japan, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 33 patents. His work primarily focuses on the development of compounds that exhibit pharmaceutical benefits, particularly in treating cancer.
Latest Patents: Among his latest patents, Sunagawa has developed a sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative. This innovation aims to provide a stable SM-108 derivative known for its effectiveness as a carcinostatic agent, especially one that maintains good storage stability. Notably, this SM-108 compound can be produced using an organic sulfonic acid salt compound, enhancing its overall stability and efficacy.
In addition to the sulfonic acid salt compound, Sunagawa has also created carbapenem compounds, represented by a detailed general formula. These compounds come with pharmaceutically acceptable salts and are designed to include specific structural configurations, which could potentially treat serious infections by mimicking and improving existing antibiotics.
Career Highlights: Throughout his career, Makoto Sunagawa has been affiliated with esteemed companies, including Sumitomo Pharmaceuticals Company Limited and Sumitomo Chemical Company, Limited. His time at these organizations has encouraged a fruitful environment for innovation and development in pharmaceutical research.
Collaborations: Sunagawa has worked alongside notable individuals in the industry, including Haruki Matsumura and Akira Sasaki. Their combined efforts have led to significant advancements in drug development, showcasing the importance of collaboration in the field of innovation.
Conclusion: With a strong foundation consisting of 33 patents and ongoing research in pharmaceuticals, Makoto Sunagawa continues to be a key player in the industry. His dedication to developing effective compounds positions him as an influential figure in the realm of medicinal chemistry and innovation, reflecting the vital link between invention and real-world applications.